Hostname: page-component-745bb68f8f-v2bm5 Total loading time: 0 Render date: 2025-01-08T11:52:05.065Z Has data issue: false hasContentIssue false
  • English
  • Français

Assessing the utility of universal preprocedure severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) testing at a cancer center

Part of: SARS-CoV-2/COVID-19

Published online by Cambridge University Press:  07 April 2022

Salma Abbas Open the ORCID record for Salma Abbas [Opens in a new window]  and
Muhammed Aasim Yusuf
Salma Abbas*
Affiliation:
Department of Internal Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Center, Johar Town, Lahore, Pakistan
Muhammed Aasim Yusuf
Affiliation:
Department of Internal Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Center, Johar Town, Lahore, Pakistan
*
Author for correspondence: Salma Abbas, MBBS, MPH, E-mail: salmaabbas@skm.org.pk
Get access Rights & Permissions [Opens in a new window]

Abstract

We implemented preprocedure severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing for cancer patients. The overall positivity rate was 0.3%. Preprocedure testing may be limited to operative procedures as community rates of SARS-CoV-2 exceed 7%. Nonoperative aerosol-generating procedures may be performed without preprocedure testing, wearing the appropriate personal protective equipment.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 44 , Issue 5 , May 2023 , pp. 824 - 826
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hanna, TP, King, WD, Thibodeau, S, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 2020;371:m4087.CrossRefGoogle ScholarPubMed
Infectious Diseases Society of America website. https://www.idsociety.org/practice-guideline/covid-19-guideline-diagnostics/. Accessed January 15, 2022.Google Scholar
American Society of Clinical Oncology website. https://www.asco.org/sites/new-www.asco.org/files/content-files/2020-ASCO-Guide-Cancer-COVID19.pdf. Accessed January 15, 2022.Google Scholar
American Gastroenterological Association website. https://gastro.org/news/new-aga-guidance-on-virus-testing-patients-before-endoscopy/. Accessed January 15, 2022.Google Scholar
American College of Surgeons website. https://www.facs.org/covid-19/clinical-guidance/resuming-elective-surgery. Accessed January 15, 2022.Google Scholar
Schlosser, M, Signorelli, H, Gregg, W, Korwek, K, Sands, K. COVID-19 testing processes and patient protections for resumption of elective surgery. Am J Surg 2021;221:49–52.CrossRefGoogle ScholarPubMed
Roberts, SC, Peaper, DR, Sussman, LS, Martinello, RA, Pettker, CM. Utility of mass SARS-CoV-2 testing of asymptomatic patients before ambulatory and inpatient preplanned procedures requiring moderate sedation or general anesthesia. JAMA Netw Open 2021;4(6):e2114526.CrossRefGoogle ScholarPubMed
Government of Pakistan website. https://covid.gov.pk/. Accessed January 15, 2022.Google Scholar
Haffner, MR, Le, HV, Saiz, AM, et al. Postoperative in-hospital morbidity and mortality of patients with COVID-19 infection compared with patients without COVID-19 infection. JAMA Netw Open 2021;4(4):e215697.CrossRefGoogle ScholarPubMed
Lewis, SS, Smith, BA, Akinboyo, IC, et al. Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area. Infect Control Hosp Epidemiol 2021;42:341–343.CrossRefGoogle Scholar